Laurus Labs (LAURUSLABS) AGM 2026 summary

Opening remarks and agenda

• Meeting conducted via audio-visual means, with e-voting and video conferencing provided for shareholder participation.

• Statutory registers and documents were available electronically; quorum was confirmed as present.

• Board members, auditors, and key executives were introduced, with some joining from international locations.

Financial performance review

• Gross margins exceeded 60%, EBITDA margins were around 28%, and net debt/EBITDA stood at 1.3x.

• Return on equity and capital employed were healthy at about 17%.

• CDMO revenue continued to grow, supporting overall company growth.

• No qualifications or adverse comments in the statutory or secretarial audit reports.

Board and executive committee updates

• Two new independent directors were proposed for appointment.

• Reappointments of directors retiring by rotation were included in the agenda.